234 related articles for article (PubMed ID: 32839151)
21. SMARCB1-Deficient Sinonasal Carcinoma: Case Report and Review of the Literature.
AlMadan NM; AlEssa EA; AlGhamdi DA
Am J Case Rep; 2023 May; 24():e939244. PubMed ID: 37198880
[TBL] [Abstract][Full Text] [Related]
22. SMARCA4-deficient Sinonasal Carcinoma: A Series of 10 Cases Expanding the Genetic Spectrum of SWI/SNF-driven Sinonasal Malignancies.
Agaimy A; Jain D; Uddin N; Rooper LM; Bishop JA
Am J Surg Pathol; 2020 May; 44(5):703-710. PubMed ID: 31934917
[TBL] [Abstract][Full Text] [Related]
23. SMARCB1 (INI1)-deficient sinonasal carcinoma manifesting as oral lesions: A report of two cases.
Fuoco J; Huang M; Esfandiari N; MacMillan C; Ali A; Dave K; Freilich M; Magalhaes M
Head Neck; 2024 Mar; 46(3):E32-E39. PubMed ID: 38088461
[TBL] [Abstract][Full Text] [Related]
24. SMARCB1 (INI1)-Deficient Sinonasal Carcinoma with Yolk Sac differentiation Showing Co-loss of SMARCA4 Immunostaining - A Case Report and Literature Review.
Ng JKM; Chan JYK; Li JJX; Tang K; Yeung DCM; Chan ABW
Head Neck Pathol; 2022 Sep; 16(3):934-941. PubMed ID: 35257325
[TBL] [Abstract][Full Text] [Related]
25. Cytomorphologic Spectrum of SMARCB1-Deficient Soft Tissue Neoplasms.
Schaefer IM; Al-Ibraheemi A; Qian X
Am J Clin Pathol; 2021 Jul; 156(2):229-245. PubMed ID: 33608696
[TBL] [Abstract][Full Text] [Related]
26. SWI/SNF-deficient head and neck neoplasms: An overview.
Agaimy A; Bishop JA
Semin Diagn Pathol; 2021 May; 38(3):175-182. PubMed ID: 33663878
[TBL] [Abstract][Full Text] [Related]
27. Loss of ARID1B and SMARCB1 expression are specific for the diagnosis of dedifferentiated/undifferentiated carcinoma in tumours of the upper gynaecological tract and cervix.
Kang EY; Tessier-Cloutier B; Duggan MA; Stewart CJR; Lee CH; Köbel M
Histopathology; 2021 Aug; 79(2):160-167. PubMed ID: 33432679
[TBL] [Abstract][Full Text] [Related]
28. Vulvar Yolk Sac Tumors Are Somatically Derived SMARCB1 (INI-1)-Deficient Neoplasms.
Kolin DL; Konstantinopoulos PA; Campos SM; Toumi G; Kolahi KA; Gars EJ; Howitt BE
Am J Surg Pathol; 2022 Feb; 46(2):169-178. PubMed ID: 34265804
[TBL] [Abstract][Full Text] [Related]
29. SMARCB1 (INI1)-deficient sinonasal carcinoma: a series of 13 cases with assessment of histologic patterns.
Kakkar A; Antony VM; Pramanik R; Sakthivel P; Singh CA; Jain D
Hum Pathol; 2019 Jan; 83():59-67. PubMed ID: 30120966
[TBL] [Abstract][Full Text] [Related]
30. SMARCB1(INI1)-deficient sinonasal adenocarcinoma: Report of a case previously diagnosed as high-grade non-intestinal-type sinonasal adenocarcinoma.
Su YJ; Lee YH; Hsieh MS
Pathol Int; 2022 Jan; 72(1):53-58. PubMed ID: 34597447
[TBL] [Abstract][Full Text] [Related]
31. Switch/sucrose nonfermenting nucleosome complex-deficient colorectal carcinomas have distinct clinicopathologic features.
Villatoro TM; Ma C; Pai RK
Hum Pathol; 2020 May; 99():53-61. PubMed ID: 32222462
[TBL] [Abstract][Full Text] [Related]
32. SMARCB1 (INI1)-deficient thyroid carcinoma: A novel entity expanding the spectrum of tumors with INI1 loss.
Agarwal S; Kakkar A; Damle NA; Kumar C; Sarangi J; Subudhi K; Jain D; Sharma MC
Pathol Res Pract; 2020 Apr; 216(4):152830. PubMed ID: 31982181
[TBL] [Abstract][Full Text] [Related]
33. Impact of Clinical Factors and Treatments on SMARCB1 (INI-1)-Deficient Sinonasal Carcinoma.
Contrera KJ; Shakibai N; Su SY; Gule-Monroe MK; Roberts D; Brahimaj B; Williams MD; Ferrarotto R; Phan J; Gunn B; Raza S; DeMonte F; Hanna EY
Otolaryngol Head Neck Surg; 2023 Aug; 169(2):435-440. PubMed ID: 36856048
[TBL] [Abstract][Full Text] [Related]
34. DNA methylation-based classification of sinonasal undifferentiated carcinoma.
Dogan S; Vasudevaraja V; Xu B; Serrano J; Ptashkin RN; Jung HJ; Chiang S; Jungbluth AA; Cohen MA; Ganly I; Berger MF; Momeni Boroujeni A; Ghossein RA; Ladanyi M; Chute DJ; Snuderl M
Mod Pathol; 2019 Oct; 32(10):1447-1459. PubMed ID: 31186531
[TBL] [Abstract][Full Text] [Related]
35. INI-1 (SMARCB1)-Deficient Undifferentiated Sinonasal Carcinoma: Novel Paradigm of Molecular Testing in the Diagnosis and Management of Sinonasal Malignancies.
Shaverdashvili K; Azimi-Nekoo E; Cohen P; Akbar N; Ow TJ; Halmos B; Castellucci E
Oncologist; 2020 Sep; 25(9):738-744. PubMed ID: 32337786
[TBL] [Abstract][Full Text] [Related]
36. SMARCB1 deficient sinonasal carcinoma: An emerging entity with a diagnostic challenge.
Anila KR; Ginju V; Vishnu VL; Kumar R; Jayasree K
Indian J Pathol Microbiol; 2023; 66(1):159-161. PubMed ID: 36656230
[TBL] [Abstract][Full Text] [Related]
37. Head and neck INI1-deficient carcinoma without primary: a case report.
Dubray-Vautrin A; Ghanem W; Bozec L; Gonin J; Choussy O
J Med Case Rep; 2023 Nov; 17(1):479. PubMed ID: 37974295
[TBL] [Abstract][Full Text] [Related]
38. Frequent IDH2 R172 mutations in undifferentiated and poorly-differentiated sinonasal carcinomas.
Dogan S; Chute DJ; Xu B; Ptashkin RN; Chandramohan R; Casanova-Murphy J; Nafa K; Bishop JA; Chiosea SI; Stelow EB; Ganly I; Pfister DG; Katabi N; Ghossein RA; Berger MF
J Pathol; 2017 Aug; 242(4):400-408. PubMed ID: 28493366
[TBL] [Abstract][Full Text] [Related]
39. SMARCB1/INI1 Deficient Sino-Nasal Carcinoma: Extending the Histomorphological Features.
Ayyanar P; Mishra P; Preetam C; Adhya AK
Head Neck Pathol; 2021 Jun; 15(2):555-565. PubMed ID: 33141418
[TBL] [Abstract][Full Text] [Related]
40. SMARC-B1 deficient sinonasal carcinoma metastasis to the brain with next generation sequencing data: a case report of perineural invasion progressing to leptomeningeal invasion.
Gomez-Acevedo H; Patterson JD; Sardar S; Gokden M; Das BC; Ussery DW; Rodriguez A
BMC Cancer; 2019 Aug; 19(1):827. PubMed ID: 31438887
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
